Remove 2017 Remove Liabilities Remove Securities and Exchange Commission (SEC)
article thumbnail

Sarepta Therapeutics (SRPT) Q4 2023 Earnings Call Transcript

The Motley Fool

The press release is available on our website at sarepta.com, and our 10-Q was filed with the Securities and Exchange Commission this afternoon. And on top of this, the patients must also secure access to ELEVIDYS in this very short time window. Uy Ear -- Mizuho Securities -- Analyst Hey, guys. Operator Thank you.

article thumbnail

Sarepta Therapeutics (SRPT) Q2 2024 Earnings Call Transcript

The Motley Fool

The press release is available on our website at sarepta.com, and our 10-Q was filed with the Securities and Exchange Commission this afternoon. We have grown revenue at about 150% CAGR from the beginning of 2017 through the end of 2023. After our formal remarks, we'll open the call for Q&A. Your line is open.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

DexCom (DXCM) Q2 2023 Earnings Call Transcript

The Motley Fool

The factors that could cause actual results to differ materially from those expressed or implied by any of these forward-looking statements are detailed in DexCom's annual report on Form 10-K, most recent quarterly report on Form 10-Q, and other filings with the Securities and Exchange Commission. Your line is open.

article thumbnail

MannKind (MNKD) Q3 2023 Earnings Call Transcript

The Motley Fool

For further information on the company's risk factors, please see their 10-Q report filed with the Securities and Exchange Commission this afternoon, the earnings release, and the slides prepared for this presentation. And our next question comes from Andreas Argyrides of Wedbush Securities. Operator Thank you.

article thumbnail

Vale (VALE) Q2 2023 Earnings Call Transcript

The Motley Fool

Securities and Exchange Commission, SEC, the Brazilian Comissao de Valores Mobiliarios CVM, and, in particular, the factors discussed under forward-looking statements and risk factors in Vale's annual report on Form 20-F. We delivered a solid production performance for our business this quarter. for the year.

article thumbnail

TechnipFMC Plc (FTI) Q2 2023 Earnings Call Transcript

The Motley Fool

Securities and Exchange Commission. when excluding foreign exchange impacts. I would like to take a moment to highlight the quality of the inbound secured in the period. Our clients are securing capacity today for project inbound that extends execution all the way out to 2030. In Subsea revenue was $1.6

article thumbnail

Atomera (ATOM) Q2 2023 Earnings Call Transcript

The Motley Fool

These risks and uncertainties are detailed in the risk factors section of our filings with the Securities and Exchange Commission, specifically the company's annual report on Form 10-K filed with the SEC on February 15, 2023. So, this started a while ago back in probably 2017, 2018, shortly after we went public.